-
Food Research International (Ottawa,... Nov 2023Coffee oligosaccharides (COS) are novel sources of prebiotics comprising manno-oligosaccharides, galacto-oligosaccharides, arabinoxylan-oligosaccharides, and... (Review)
Review
Coffee oligosaccharides (COS) are novel sources of prebiotics comprising manno-oligosaccharides, galacto-oligosaccharides, arabinoxylan-oligosaccharides, and cello-oligosaccharides. These oligosaccharides function as prebiotics, antioxidant-dietary fiber owing to important physicochemical and physiological properties, adjuvants, pharma, nutraceutical food, gut health, immune system boosting, cancer treatment, and many more. Research suggests COS performs prebiotic action, as it enhances gut health by promoting beneficial bacteria in the colon and releasing functional metabolites such as SCFAs. However, research on COS concerning other metabolic illnesses is still lacking. Among various production strategies, pretreatment and enzymatic hydrolysis are preferred for the production of COS. Functional oligosaccharides can add value to coffee waste and reduce the environmental impact of coffee manufacturing, besides providing more options for healthy and active ingredients. This review updates COS, production, bio-activity, their role as a functional food, food supplements/natural food additives, prebiotics and many applications of health sectors. Research is desirable to extend information on COS and their bio-activity, besides in vivo and clinical trials, to assess their effects in prior human formulations into the food and therapeutic arena.
Topics: Humans; Coffee; Prebiotics; Dietary Supplements; Oligosaccharides; Dietary Fiber
PubMed: 37803601
DOI: 10.1016/j.foodres.2023.113288 -
International Journal of Biological... Jan 2024Hazelnut is one of the most popular nuts in the world, rich in nutrients and various active substances. In this study, soluble dietary fiber (SDF) was extracted from...
Hazelnut is one of the most popular nuts in the world, rich in nutrients and various active substances. In this study, soluble dietary fiber (SDF) was extracted from hazelnut kernels, and its physicochemical properties and absorbability were explored. Hazelnut-SDF exhibited ideal water-holding, oil-holding and swelling capacity, and glucose, cholesterol and cholate absorbing ability. Scanning electron microscopy and fourier transform infrared spectroscopy showed that hazelnut-SDF had typical polysaccharide structure of functional groups. The main monosaccharides were identified as arabinose, rhamnose, xylose, ribose, glucuronic acid, mannose and glucose by gas chromatography-mass spectrometry. In high-fat diet rats, hazelnut-SDF could improve serum lipid parameters, inhibit lipid accumulation in liver and adipocytes, and regulate the expression level of liver lipid synthesis-related genes. It also could adjust intestinal short chain fatty acids, promote the composition and structure of intestinal microbiota, and significantly balance the abundance of Alloprevotella, Fusicatenibacter, Lactobacillus, Roseburia, Ruminococcaceae_UCG-005, Ruminococcaceae_UCG-014 and Clostridiales. The results concluded that oral administration of hazelnut-SDF could alleviate hyperlipidemia and obesity, and might serve as a potential functional food ingredient.
Topics: Rats; Animals; Diet, High-Fat; Gastrointestinal Microbiome; Corylus; Dietary Fiber; Cholesterol; Glucose
PubMed: 38043651
DOI: 10.1016/j.ijbiomac.2023.128538 -
Nutrients Apr 2024Inflammation is an important biological response to any tissue injury. The immune system responds to any stimulus, such as irritation, damage, or infection, by releasing... (Review)
Review
Inflammation is an important biological response to any tissue injury. The immune system responds to any stimulus, such as irritation, damage, or infection, by releasing pro-inflammatory cytokines. The overproduction of pro-inflammatory cytokines can lead to several diseases, e.g., cardiovascular diseases, joint disorders, cancer, and allergies. Emerging science suggests that whole grains may lower the markers of inflammation. Whole grains are a significant source of dietary fiber and phenolic acids, which have an inverse association with the risk of inflammation. Both cereals and pseudo-cereals are rich in dietary fiber, e.g., arabinoxylan and β-glucan, and phenolic acids, e.g., hydroxycinnamic acids and hydroxybenzoic acids, which are predominantly present in the bran layer. However, the biological mechanisms underlying the widely reported association between whole grain consumption and a lower risk of disease are not fully understood. The modulatory effects of whole grains on inflammation are likely to be influenced by several mechanisms including the effect of dietary fiber and phenolic acids. While some of these effects are direct, others involve the gut microbiota, which transforms important bioactive substances into more beneficial metabolites that modulate the inflammatory signaling pathways. Therefore, the purpose of this review is twofold: first, it discusses whole grain dietary fiber and phenolic acids and highlights their potential; second, it examines the health benefits of these components and their impacts on subclinical inflammation markers, including the role of the gut microbiota. Overall, while there is promising evidence for the anti-inflammatory properties of whole grains, further research is needed to understand their effects fully.
Topics: Humans; Whole Grains; Phenols; Inflammation; Dietary Fiber; Cytokines; Hydroxybenzoates
PubMed: 38613080
DOI: 10.3390/nu16071047 -
Current Opinion in Clinical Nutrition... Jul 2023Glycemia goals are used as indicators of control and progression in prediabetes and diabetes. Adopting healthy eating habits is essential. It is worth considering the... (Review)
Review
PURPOSE OF REVIEW
Glycemia goals are used as indicators of control and progression in prediabetes and diabetes. Adopting healthy eating habits is essential. It is worth considering the quality of carbohydrates to help with dietary glycemic control. The present article aims to review recent meta-analyses published in the years 2021-2022 on the effects of dietary fiber and low glycemic index/load (LGI/LGL) foods on glycemic control and how gut microbiome modulation contributes to glycemic control.
RECENT FINDINGS
Data involving more than 320 studies were reviewed. The evidence allows us to infer that LGI/LGL foods, including dietary fiber intake, are associated with reduced fasting glycemia and insulinemia, postprandial glycemic response, HOMA-IR, and glycated hemoglobin, which are more evident in soluble dietary fiber. These results can be correlated with changes in the gut microbiome. However, the mechanistic roles of microbes or metabolites implicated in these observations continue to be explored. Some controversial data highlight the need for more homogeneity between studies.
SUMMARY
The properties of dietary fiber are reasonably well established for their glycemic homeostasis effects, including the fermentation aspects. Findings of gut microbiome correlations with glucose homeostasis can be incorporated into clinical nutrition practice. Target dietary fiber interventions on microbiome modulation can offer options to improve glucose control and contribute to personalized nutritional practices.
Topics: Humans; Blood Glucose; Dietary Carbohydrates; Glycemic Index; Dietary Fiber; Microbiota; Diabetes Mellitus, Type 2
PubMed: 37144465
DOI: 10.1097/MCO.0000000000000935 -
Microbiology Spectrum Aug 2023Red ginseng, widely used in traditional medicine for various conditions, imparts health benefits mainly by modulating the gut microbiota in humans. Given the...
Red ginseng, widely used in traditional medicine for various conditions, imparts health benefits mainly by modulating the gut microbiota in humans. Given the similarities in gut microbiota between humans and dogs, red ginseng-derived dietary fiber may have prebiotic potential in dogs; however, its effects on the gut microbiota in dogs remain elusive. This double-blinded, longitudinal study investigated the impact of red ginseng dietary fiber on the gut microbiota and host response in dogs. A total of 40 healthy household dogs were randomly assigned to low-dose ( = 12), high-dose ( = 16), or control ( = 12) groups and fed a normal diet supplemented with red ginseng dietary fiber (3 g/5 kg body weight per day, 8 g/5 kg per day, or no supplement, respectively) for 8 weeks. The gut microbiota of the dogs was analyzed at 4 weeks and 8 weeks using 16S rRNA gene sequencing of fecal samples. Alpha diversity was significantly increased at 8 and 4 weeks in the low-dose and high-dose groups, respectively. Moreover, biomarker analysis showed that short-chain fatty acid producers such as and were significantly enriched, while potential pathogens such as were significantly decreased, indicating the increased gut health and pathogen resistance by red ginseng dietary fiber. Microbial network analysis showed that the complexity of microbial interactions was increased by both doses, indicating the increased stability of the gut microbiota. These findings suggest that red ginseng-derived dietary fiber could be used as a prebiotic to modulate gut microbiota and improve gut health in dogs. The canine gut microbiota is an attractive model for translational studies, as it responds to dietary interventions similarly to those in humans. Investigating the gut microbiota of household dogs that share the environment with humans can produce highly generalizable and reproducible results owing to their representativeness of the general canine population. This double-blind and longitudinal study investigated the impact of dietary fiber derived from red ginseng on the gut microbiota of household dogs. Red ginseng dietary fiber altered the canine gut microbiota by increasing diversity, enriching short-chain fatty acid-producing microbes, decreasing potential pathogens, and increasing the complexity of microbial interactions. These findings indicate that red ginseng-derived dietary fiber may promote canine gut health by modulating gut microbiota, suggesting the possibility of its use as a potential prebiotic.
Topics: Animals; Dogs; Dietary Fiber; Double-Blind Method; Fatty Acids, Volatile; Feces; Gastrointestinal Microbiome; Longitudinal Studies; Panax; Prebiotics; RNA, Ribosomal, 16S
PubMed: 37367492
DOI: 10.1128/spectrum.00949-23 -
Nutrients Nov 2023Only 9% of individuals in the United Kingdom (UK) meet the recommendation for dietary fibre intake. Little is known about chickpea consumption in the UK. Chickpea...
Only 9% of individuals in the United Kingdom (UK) meet the recommendation for dietary fibre intake. Little is known about chickpea consumption in the UK. Chickpea intake trends and sociodemographic patterns were analysed using the National Diet and Nutrition Survey Rolling Programme data collected from 2008/09 to 2018/19 among 15,655 individuals ≥1.5 years completing a four-day food diary. Chickpea consumers were identified based on a list of chickpea-containing foods, with the most consumed foods being hummus, boiled chickpeas, chickpea flour, and low/reduced-fat hummus. Micronutrient and food group intakes were compared between chickpea consumers and non-consumers; the Modified Healthy Dietary Score was also assessed, which measures adherence to UK dietary recommendations. Chickpea consumption increased from 6.1% (2008-2012) to 12.3% (2016-2019). Among 1.5-3 years, consumption increased from 5.7% to 13.4%, and among 19-64 years, consumption increased from 7.1% to 14.4%. The percentage of individuals eating chickpeas was higher among individuals with higher incomes and more education. Healthy-weight adults were more likely to consume chickpeas compared to those who were overweight or obese. Compared to both bean and non-bean consumers, chickpea consumers ate significantly more dietary fibre, fruits and vegetables, pulses, nuts, and less red meat and processed meat products. Chickpea consumers also had a higher Modified Healthy Dietary Score. In the UK, chickpea consumption more than doubled from 2008/09 to 2018/19. Chickpea consumers had a higher diet quality than non-consumers.
Topics: Adult; Humans; Cicer; Diet; Fruit; Vegetables; Nutrition Surveys; Dietary Fiber; Energy Intake
PubMed: 38004178
DOI: 10.3390/nu15224784 -
Nutrition (Burbank, Los Angeles County,... Jul 2023Recent studies have found that dietary fiber improves prognosis in cancer patients. However, few subgroup analyses exist. Subgroups can differ greatly in terms of... (Clinical Trial)
Clinical Trial
Higher dietary fiber intake associated with better survival in male but not female cancer patients: Evidence from National Health and Nutrition Examination Survey 1999-2014.
OBJECTIVES
Recent studies have found that dietary fiber improves prognosis in cancer patients. However, few subgroup analyses exist. Subgroups can differ greatly in terms of different factors such as dietary intake, lifestyle, and sex. It is unclear whether fiber benefits all of the subgroups equally. In this study, we examined differences in dietary fiber consumption and cancer mortality between subgroups, including sex.
METHODS
This trial was conducted using eight consecutive National Health and Nutrition Examination Surveys (NHANESs) cycles data between 1999 and 2014. Subgroup analyses were used to investigate the results and heterogeneity within subgroups. Survival analysis was performed using the Cox proportional hazard model and Kaplan-Meier curves. Multivariable Cox regression models and restricted cubic spline analysis were applied to examine the association between dietary fiber intake and mortality.
RESULTS
In total, 3504 cases were included in this study. Among the participants, the mean age (SD) was 65.5 (15.7) y and 1657 (47.3%) of the participants were men. Subgroup analysis found that men differed significantly from women (P for interaction < 0.001). We found no significant differences in the other subgroups (all P for interaction > 0.05). During an average follow-up of 6.8 y, 342 cancer deaths were recorded. The Cox regression models found that fiber consumption was associated with a lower cancer mortality rate in men (model I: hazard ratio [HR] = 0.60; 95% CI, 0.50-0.72; model II: HR = 0.60; 95% CI, 0.47-0.75; and model III: HR = 0.61; 95% CI, 0.48-0.77). However, there was no relationship between fiber consumption and cancer mortality in women (model I: HR = 1.06; 95% CI, 0.88-1.28; model II: HR = 1.03; 95% CI, 0.84-1.26; and model III: HR = 1.04; 95% CI, 0.87-1.50). The Kaplan-Meier curve illustrates that male patients who consumed higher levels of dietary fiber survived significantly longer than those who consumed lower levels of fiber (P < 0.001). However, there were no significant differences between the two groups in terms of female patients (P = 0.84). A dose-response analysis found an L-shaped relationship between fiber intake and mortality among men.
CONCLUSIONS
This study found that higher dietary fiber intake was only associated with better survival in male cancer patients, not in female cancer patients. Sex differences between dietary fiber intake and cancer mortality were observed.
Topics: Female; Humans; Male; Cardiovascular Diseases; Dietary Fiber; Eating; Neoplasms; Nutrition Surveys; Risk Factors; Middle Aged; Aged; Aged, 80 and over
PubMed: 37149919
DOI: 10.1016/j.nut.2023.112035 -
International Journal of Biological... Feb 2024Functional gastrointestinal disorders (FGIDs) are a group of chronic or recurrent gastrointestinal functional diseases, including functional dyspepsia, irritable bowel... (Review)
Review
Functional gastrointestinal disorders (FGIDs) are a group of chronic or recurrent gastrointestinal functional diseases, including functional dyspepsia, irritable bowel syndrome, and functional constipation. A lack of safe and reliable treatments for abdominal pain-related FGIDs has prompted interest in new therapies. Evidence has shown that supplementation with dietary fiber may help treat FGIDs. Dietary fibers (DFs) have been demonstrated to have regulatory effects on the gut microbiota, microbiota metabolites, and gastrointestinal movement and have important implications for preventing and treating FGIDs. However, the adverse effects of some DFs, such as fermentable oligosaccharides, on FGIDs are unclear. This review provides an overview of the DFs physiological properties and functional characteristics that influence their use in management of FGIDs, with emphasis on structural modification technology to improve their therapeutic activities. The review highlights that the use of appropriate or novel fibers is a potential therapeutic approach for FGIDs.
Topics: Humans; Gastrointestinal Diseases; Abdominal Pain; Dietary Fiber; Polysaccharides; Oligosaccharides
PubMed: 38128805
DOI: 10.1016/j.ijbiomac.2023.128835 -
Nature Reviews. Gastroenterology &... May 2024Obesity and metabolic syndrome represent a growing epidemic worldwide. Body weight is regulated through complex interactions between hormonal, neural and metabolic... (Review)
Review
Obesity and metabolic syndrome represent a growing epidemic worldwide. Body weight is regulated through complex interactions between hormonal, neural and metabolic pathways and is influenced by numerous environmental factors. Imbalances between energy intake and expenditure can occur due to several factors, including alterations in eating behaviours, abnormal satiation and satiety, and low energy expenditure. The gut microbiota profoundly affects all aspects of energy homeostasis through diverse mechanisms involving effects on mucosal and systemic immune, hormonal and neural systems. The benefits of dietary fibre on metabolism and obesity have been demonstrated through mechanistic studies and clinical trials, but many questions remain as to how different fibres are best utilized in managing obesity. In this Review, we discuss the physiochemical properties of different fibres, current findings on how fibre and the gut microbiota interact to regulate body weight homeostasis, and knowledge gaps related to using dietary fibres as a complementary strategy. Precision medicine approaches that utilize baseline microbiota and clinical characteristics to predict individual responses to fibre supplementation represent a new paradigm with great potential to enhance weight management efficacy, but many challenges remain before these approaches can be fully implemented.
Topics: Dietary Fiber; Humans; Obesity; Gastrointestinal Microbiome; Energy Metabolism
PubMed: 38326443
DOI: 10.1038/s41575-023-00891-z -
Gut Microbes Dec 2023Dietary fiber plays a crucial role in maintaining gut and overall health. The objective of this study was to investigate whether different types of dietary fiber...
Dietary fiber plays a crucial role in maintaining gut and overall health. The objective of this study was to investigate whether different types of dietary fiber elicited specific changes in gut microbiota composition and the production of short-chain fatty acids. To test this, a longitudinal crossover study design was employed, in which healthy adult women consumed three distinct dietary fiber supplements: Inulin (fructo-oligosaccharide), Vitafiber (isomalto-oligosaccharide), and Fibremax (mixture of different fiber) during a one-week intervention period, followed by a 2-week washout period. A total of 15 g of soluble fiber was consumed daily for each supplement. Samples were collected before and after each intervention to analyze the composition of the gut microbiota by 16S rRNA sequencing and fecal levels of short-chain fatty acids measured using nuclear magnetic resonance. Phenotypic changes in peripheral blood mononuclear cells were studied in subsets of participants with higher SCFA levels post-intervention using spectral flow cytometry. The results revealed substantial stability and resilience of the overall gut bacterial community toward fiber-induced changes. However, each supplement had specific effects on gut bacterial alpha and beta diversity, SCFA production, and immune changes. Inulin consistently exerted the most pronounced effect across individuals and certain taxa were identified as potential indicators of SCFA production in response to inulin supplementation. This distinguishing feature was not observed for the other fiber supplements. Further large-scale studies are required to confirm these findings. Overall, our study implies that personalized dietary fiber intervention could be tailored to promote the growth of beneficial bacteria to maximize SCFA production and associated health benefits.
Topics: Adult; Female; Humans; Bacteria; Cross-Over Studies; Dietary Fiber; Fatty Acids, Volatile; Feces; Gastrointestinal Microbiome; Immunity; Inulin; Leukocytes, Mononuclear; Oligosaccharides; RNA, Ribosomal, 16S; Longitudinal Studies
PubMed: 37942526
DOI: 10.1080/19490976.2023.2274127